000 | 01029 a2200301 4500 | ||
---|---|---|---|
005 | 20250511183606.0 | ||
264 | 0 | _c19921222 | |
008 | 199212s 0 0 eng d | ||
022 | _a0828-282X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDavignon, J | |
245 | 0 | 0 |
_aHMG-CoA reductase inhibitors: a look back and a look ahead. _h[electronic resource] |
260 |
_bThe Canadian journal of cardiology _cOct 1992 |
||
300 |
_a843-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl CoA Reductases _xphysiology |
650 | 0 | 4 | _aHydroxymethylglutaryl-CoA Reductase Inhibitors |
650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xdrug therapy |
650 | 0 | 4 |
_aHypolipidemic Agents _xadverse effects |
700 | 1 | _aMontigny, M | |
700 | 1 | _aDufour, R | |
773 | 0 |
_tThe Canadian journal of cardiology _gvol. 8 _gno. 8 _gp. 843-64 |
|
999 |
_c1429494 _d1429494 |